High expression of CD36 (Figure 10A, p = 0.001), ENO3 (Figure 10B, p < 0.001), MORC2 (Figure 10C, p < 0.001) and ELOVL3 (Figure 10D, p = 0.007) predicted poor overall survival in COAD patients. Here, ELOVL3 is linked to colon adenocarcinoma.